EXIR is a focused Pharmaceutical company with one of the broadest antibiotics portfolio in the industry, including the most advanced products with the area of cephalosporin.

EXIR is a leader in infections care. In addition, EXIR has a leading position in the areas such as diabetes management, growth hormone therapy and treatment of CNS and GI diseases.

 

EXIR manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.